Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use
Slim Fourati, Alexandre Soulier, Aurélie Gourgeon, Souraya Khouider, Camille Langlois, Arnaud Galbin, Anne Le Bouter, Christophe Rodriguez, Marie Joanny, Amélie Dublineau, Dominique Challine, Magali Bouvier‐Alias, Stéphane Chevaliez, Étienne Audureau, Jean–Michel Pawlotsky
Topics & Concepts
ImmunoassaySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakHigh-throughput screeningAntigenComputational biologyBiologyMedicineImmunologyAntibodyBioinformaticsOutbreakInfectious disease (medical specialty)PathologyDiseaseSARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchBiosensors and Analytical Detection